Presence of Embolic Source and Outcome in Central Retinal Artery Occlusion.

Kang, Dong-Wan; Jung, Keun-Hwa; Yang, Wookjin; Kim, Hyeong Min; Kim, Youngjoon; Chung, Matthew; Ha, Jiyeon; Punsalan, Monique Therese et al. · Neurology · 2023

retrospective_cohort · Level III

Where this comes from

Abstract

The etiology of central retinal artery occlusion (CRAO) is unclear in approximately 50% of patients, suggesting pathomechanical heterogeneity; moreover, little is known about outcomes according to etiology. This study investigated whether the presence of an embolic source affects outcome in CRAO. CRAO patients within 7 days of symptom onset were retrospectively enrolled. Clinical parameters, including initial and 1-month visual acuity, CRAO subtype, and brain images, were reviewed. CRAO etiology was categorized as CRAO with or without an embolic source (CRAO-E<sup>+</sup> and CRAO-E<sup>-</sup>). Visual improvement was defined as a decrease in logarithm of the minimum angle of resolution ≥0.3 at 1 month. A total of 114 patients with CRAO were included. Visual improvement was noted in 40.4% of patients. Embolic sources were identified in 55.3% of patients, and visual improvement group rather than no improvement group was more commonly associated with the presence of an embolic source. In multivariable logistic regression analysis, CRAO-E<sup>+</sup> independently predicted visual improvement (odds ratio 3.00, 95% CI 1.15-7.81, <i>p</i> = 0.025). CRAO-E<sup>+</sup> was found to be associated with a better outcome. CRAO-E<sup>+</sup> may be more prone to recanalization than that CRAO-E<sup>-</sup>.

Medical subject headings